Is Novo Nordisk Stock a Buy?

Few companies garner as much reliable attention as Novo Nordisk (NVO) does these days. With a bull market coinciding with a historic run of growth for the Danish pharmaceutical giant related to its GLP-1 drugs, it's no surprise that its share prices have nearly doubled over the last three years.But with such strong performance lately, can the stock be as good a purchase for investors going forward? To find out, let's take a look at what it has planned.There's no shortage of reasons to buy hereNovo Nordisk i ...